Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,741 | 588 | 99.7% |
| Education | $25.02 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,092 | 73 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $775.63 | 55 | $0 (2021) |
| Amgen Inc. | $728.12 | 46 | $0 (2021) |
| ABBVIE INC. | $607.89 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $543.21 | 44 | $0 (2021) |
| Lilly USA, LLC | $537.35 | 45 | $0 (2021) |
| PFIZER INC. | $482.69 | 48 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $428.13 | 5 | $0 (2021) |
| Astellas Pharma US Inc | $400.19 | 22 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $338.24 | 31 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.59 | 1 | ABBVIE INC. ($16.59) |
| 2023 | $47.07 | 2 | Abbott Laboratories ($23.92) |
| 2022 | $35.91 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($18.16) |
| 2021 | $2,221 | 154 | AbbVie Inc. ($333.18) |
| 2020 | $584.07 | 30 | E.R. Squibb & Sons, L.L.C. ($124.55) |
| 2019 | $1,740 | 111 | Amgen Inc. ($256.24) |
| 2018 | $2,011 | 126 | Novo Nordisk Inc ($364.70) |
| 2017 | $2,111 | 166 | Novo Nordisk Inc ($331.07) |
All Payment Transactions
592 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: ONCOLOGY | ||||||
| 12/25/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Vascular | ||||||
| 05/24/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/03/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Gastroenterology | ||||||
| 12/20/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Cardio-renal | ||||||
| 12/15/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Diabetes | ||||||
| 12/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Neuroscience | ||||||
| 12/09/2021 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $36.30 | General |
| 12/07/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/06/2021 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Bone Health | ||||||
| 11/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: DIABETES | ||||||
| 11/23/2021 | Almatica Pharma LLC | LOREEV XR (Drug), GRALISE | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 11/19/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Diabetes | ||||||
| 11/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/15/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: PRIMARY CARE | ||||||
| 11/09/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: UROLOGY | ||||||
| 11/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: Diabetes | ||||||
| 11/07/2021 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: VACCINES | ||||||
| 11/03/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 10 | 1,142 | 1,882 | $303,286 | $119,679 |
| 2020 | 24 | 2,230 | 3,042 | $392,923 | $125,072 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 423 | 979 | $200,695 | $77,918 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 163 | 163 | $52,812 | $20,840 | 39.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 168 | 242 | $33,638 | $15,044 | 44.7% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 32 | 32 | $5,856 | $1,993 | 34.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 12 | 12 | $2,064 | $1,505 | 72.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 258 | 350 | $3,150 | $1,045 | 33.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 33 | 33 | $2,310 | $519.42 | 22.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 15 | $1,260 | $441.98 | 35.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 15 | $1,050 | $236.44 | 22.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 24 | 41 | $451.00 | $137.12 | 30.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 438 | 878 | $179,990 | $55,843 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 213 | 213 | $69,012 | $23,523 | 34.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 193 | 264 | $36,696 | $10,812 | 29.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 56 | 166 | $23,074 | $8,897 | 38.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 66 | 69 | $6,417 | $4,037 | 62.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 39 | 47 | $9,541 | $3,851 | 40.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 216 | 219 | $12,483 | $2,862 | 22.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 29 | 33 | $6,435 | $2,425 | 37.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 225 | 233 | $10,485 | $2,403 | 22.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 15 | 15 | $3,975 | $1,597 | 40.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 71 | 74 | $5,180 | $1,159 | 22.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 21 | 42 | $3,234 | $1,144 | 35.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 287 | 380 | $3,420 | $1,120 | 32.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 101 | 122 | $4,026 | $928.42 | 23.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $3,105 | $875.35 | 28.2% |
About Dr. Robert Brown, MD
Dr. Robert Brown, MD is a Internal Medicine healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134162209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Brown, MD has received a total of $8,766 in payments from pharmaceutical and medical device companies, with $16.59 received in 2024. These payments were reported across 592 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,741).
As a Medicare-enrolled provider, Brown has provided services to 3,372 Medicare beneficiaries, totaling 4,924 services with total Medicare billing of $244,752. Data is available for 2 years (2020–2021), covering 34 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Savannah, GA
- Active Since 06/14/2006
- Last Updated 01/28/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134162209
Products in Payments
- FARXIGA (Drug) $571.85
- JARDIANCE (Drug) $544.61
- ELIQUIS (Drug) $467.82
- Ozempic (Drug) $414.74
- MYRBETRIQ (Drug) $376.39
- TRULICITY (Drug) $278.16
- XARELTO (Drug) $250.06
- Victoza (Drug) $249.85
- Aimovig (Biological) $237.68
- Livalo (Drug) $232.33
- Tresiba (Drug) $226.85
- NEXLETOL (Drug) $204.94
- VRAYLAR (Drug) $204.23
- UBRELVY (Drug) $203.09
- FlexAbility Ablation Catheter (Device) $184.34
- CHANTIX (Drug) $178.52
- Vascepa (Drug) $157.48
- EVENITY (Biological) $157.24
- Androgel (Drug) $136.09
- SYMBICORT (Drug) $132.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Savannah
Dr. Jennifer Woehler, D.o, D.O
Internal Medicine — Payments: $183,589
Dr. Michael Perkins, M.d, M.D
Internal Medicine — Payments: $68,118
Paul Bradley, Md, MD
Internal Medicine — Payments: $33,506
John Demicco, M.d, M.D
Internal Medicine — Payments: $32,210
Dr. Timothy Connelly, Md, MD
Internal Medicine — Payments: $24,711
Wilfredo Dolor, Md, MD
Internal Medicine — Payments: $20,320